Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;3(3):229-235.
doi: 10.1302/2633-1462.33.BJO-2021-0203.R1.

Proximal femoral replacement in non-neoplastic revision hip arthroplasty : five-year results

Affiliations

Proximal femoral replacement in non-neoplastic revision hip arthroplasty : five-year results

Kevin Syam et al. Bone Jt Open. 2022 Mar.

Abstract

Aims: With increasing burden of revision hip arthroplasty (THA), one of the major challenges is the management of proximal femoral bone loss associated with previous multiple surgeries. Proximal femoral arthroplasty (PFA) has already been popularized for tumour surgeries. Our aim was to describe the outcome of using PFA in these demanding non-neoplastic cases.

Methods: A retrospective review of 25 patients who underwent PFA for non-neoplastic indications between January 2009 and December 2015 was undertaken. Their clinical and radiological outcome, complication rates, and survival were recorded. All patients had the Stanmore Implant - Modular Endo-prosthetic Tumour System (METS).

Results: At mean follow-up of 5.9 years, there were no periprosthetic fractures. Clearance of infection was achieved in 63.6% of cases. One hip was re-revised to pseudo arthroplasty for deep infection. Instability was noted in eight of the hips (32%), of which seven needed further surgery. Out of these eight hips with instability, five had preoperative infection. Deep infection was noted in five of the hips (20%), of which four were primarily revised for infection. One patient had aseptic loosening of the femoral component and awaits revision surgery. The Kaplan-Meier survivorship free of revision of any component for any reason was 72% (95% confidence interval (CI) 51.3% to 92.7%), and for revisions of only femoral component for any reason was 96% (95% CI 86.3% to 105.7%) at five years.

Conclusion: Dislocation and infection remain the major cause for failure, particularly in patients with pre-existing infection. The use of dual mobility cups, silver-coated implants, and less aggressive postoperative rehabilitation regimens would possibly aid in the reduction of complications. PFA performed in patients with periprosthetic fracture seem to fair better. This study supports the judicious use of PFA in non-oncological revision hip arthroplasties, and that they be performed by experienced revision arthroplasty surgeons. Cite this article: Bone Jt Open 2022;3(3):229-235.

Keywords: Endoprosthetic replacement; Femoral bone loss; Proximal femoral replacement; Revision hip arthroplasty; dual mobility cups; femoral component; hips; infection; joint arthroplasty; periprosthetic fractures; proximal femoral arthroplasties; revision arthroplasty; revision hip arthroplasties; revision surgery.

PubMed Disclaimer

Conflict of interest statement

ICMJE COI statement: The authors confirm that they have no disclosures to declare.

Figures

Fig. 1
Fig. 1
Pie diagram depicting indications for proximal femoral arthroplasty.
Fig. 2
Fig. 2
a) Preoperative radiograph of a failed periprosthetic fracture fixation with profound bone loss. b) Postoperative radiograph at nine years follow-up.
Fig. 3
Fig. 3
Flow chart depicting complications and their management.
Fig. 4
Fig. 4
Graphical representation of Kaplan-Meier curve for revision of femoral component only for any reason.
Fig. 5
Fig. 5
Graphical representation of Kaplan-Meier curve for revision of any component for any reason.
Fig. 6
Fig. 6
Graphical representation of Kaplan-Meier curve for revision of any femoral or acetabular component for any reason, excluding application of posterior lip augmentation device.

References

    1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89-A(4):780–785. 10.2106/JBJS.F.00222 - DOI - PubMed
    1. Howard P, Brittain R, Lawrence S, et al. . National Joint Registry 17th annual report. 2020. https://www.njrcentre.org.uk/njrcentre/default.aspx (date last accessed 11 February 2022). - PubMed
    1. Swarup I, Lee Y-Y, Chiu Y-F, Sutherland R, Shields M, Figgie MP. Implant survival and patient-reported outcomes after total hip arthroplasty in young patients. J Arthroplasty. 2018;33(9):2893–2898. 10.1016/j.arth.2018.04.016 - DOI - PubMed
    1. Parvizi J, Sim FH. Proximal femoral replacements with megaprostheses. Clin Orthop Relat Res. 2004;420:169–175. 10.1097/00003086-200403000-00023 - DOI - PubMed
    1. Parvizi J, Tarity TD, Slenker N, et al. . Proximal femoral replacement in patients with non-neoplastic conditions. J Bone Joint Surg Am. 2007;89-A(5):1036–1043. 10.2106/JBJS.F.00241 - DOI - PubMed